secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edesa Biotech, Inc. (EDSA)
CIK:        0001540159
Form:       8-K
Filed at:   2024-05-30T23:59:59+00:00
Accession:  0001654954-24-007083
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edesa Biotech shareholders approve 67,000-share increase to equity plan, re-elect all directors
--------------------------------------------------------------------------------

- All seven director nominees elected with ~818-819 thousand votes for each; 654k broker non-votes.
- Advisory vote on executive compensation approved: 677,967 for, 122,761 against, 62,400 abstain.
- Plan amendment increasing shares by 67,000 approved: 660,015 for, 151,395 against, 51,718 abstain.
- Approximately 47% of outstanding shares (1,517,529) represented at the meeting.
- MNP LLP appointed as auditors for FY ending Sept 30, 2024 with 1,463,707 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1540159/000165495424007083/0001654954-24-007083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1540159/000165495424007083/edsa_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-007083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer